Correction: Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
[This corrects the article DOI: 10.1371/journal.pone.0215981.].
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0223429 |
Similar Items
-
Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
by: Alzahrani Abdullah, et al.
Published: (2019-01-01) -
Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor
by: Pei-Xin Shen, et al.
Published: (2021-02-01) -
Correction: Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
by: PLOS ONE Staff
Published: (2016-01-01) -
The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor.
by: Edmond F O'Donnell, et al.
Published: (2010-10-01) -
Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.
by: Hamza Hanieh, et al.
Published: (2016-01-01)